• Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

  • Apr 30 2024
  • Duración: 34 m
  • Podcast

Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents Por arte de portada

Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
activate_primeday_promo_in_buybox_DT
Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles